• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 84 páginas
Examen

NRNP 6552 WEEK 6 MIDTERM EXAM 2026 | Advanced Reproductive Health Care | 100 Questions & Verified Answers | Walden University | Pass Guaranteed - A+ Graded

Document preview thumbnail
Vista previa 4 fuera de 84 páginas

Pass the NRNP 6552 Week 6 Midterm Exam on your first attempt with this complete 2026 updated guide for Advanced Reproductive Health Care at Walden University. This A+ Graded resource contains 100 questions and verified answers covering all key content areas for the Week 6 midterm exam including female reproductive anatomy and physiology (ovarian cycle, menstrual cycle phases (follicular, ovulatory, luteal), hormonal regulation (estrogen, progesterone, FSH, LH, GnRH)), male reproductive anatomy and physiology (spermatogenesis, hormonal control, erectile function), preconception counseling (risk assessment, genetic screening, folic acid supplementation, lifestyle modifications), contraception comprehensive management (combined oral contraceptives (monophasic, multiphasic), progestin-only pills, transdermal patch, vaginal ring (NuvaRing, Annovera), depot medroxyprogesterone acetate (DMPA/Depo-Provera), etonogestrel implant (Nexplanon), copper IUD (Paragard), levonorgestrel IUDs (Mirena, Kyleena, Liletta, Skyla), barrier methods (external/internal condoms, diaphragm, cervical cap, contraceptive sponge), spermicides, fertility awareness-based methods (standard days method, basal body temperature, cervical mucus monitoring, symptothermal method), lactational amenorrhea method (LAM), emergency contraception (ulipristal acetate (Ella), levonorgestrel (Plan B One-Step, Take Action), copper IUD for emergency contraception), and permanent sterilization (tubal ligation, bilateral salpingectomy, hysteroscopic sterilization (Essure discontinued), vasectomy), infertility evaluation and management (female factor (ovulatory disorders, tubal factor, uterine factor, cervical factor, endometriosis), male factor (semen analysis abnormalities, varicocele, hormonal disorders), diagnostic testing (ovulation assessment (LH surge, progesterone level), ovarian reserve testing (FSH, estradiol, AMH, antral follicle count), hysterosalpingography (HSG), sonohysterography, hysteroscopy, laparoscopy, semen analysis (WHO criteria), treatment options (ovulation induction (clomiphene citrate, letrozole, gonadotropins), intrauterine insemination (IUI), in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), donor gametes, surrogacy), sexually transmitted infections (STIs) comprehensive screening (USPSTF guidelines), diagnosis, and management (chlamydia trachomatis (azithromycin, doxycycline), neisseria gonorrhoeae (ceftriaxone plus azithromycin/doxycycline), treponema pallidum (syphilis) (benzathine penicillin G, doxycycline for late latent), herpes simplex virus (HSV-1, HSV-2) (acyclovir, valacyclovir, famciclovir for episodic or suppressive therapy), human papillomavirus (HPV) (vaccination (Gardasil 9), management of anogenital warts (patient-applied (podofilox, imiquimod, sinecatechins) and provider-administered (cryotherapy, TCA, surgical removal)), human immunodeficiency virus (HIV) (PrEP (Truvada, Descovy), PEP, ART, perinatal transmission prevention), trichomonas vaginalis (metronidazole, tinidazole), mycoplasma genitalium (azithromycin, moxifloxacin), bacterial vaginosis (metronidazole, clindamycin, tinidazole), vulvovaginal candidiasis (azoles (miconazole, clotrimazole, fluconazole) for uncomplicated and complicated infections), pelvic inflammatory disease (PID) (CDC outpatient (ceftriaxone plus doxycycline with or without metronidazole) and inpatient regimens), vulvovaginal conditions (lichen sclerosus (ultrapotent topical corticosteroids), lichen planus (topical corticosteroids, tacrolimus), vulvodynia (multidisciplinary approach (cognitive behavioral therapy, pelvic floor physical therapy, topical lidocaine, tricyclic antidepressants, SNRIs, gabapentin/pregabalin)), vaginismus (pelvic floor physical therapy, dilators, botulinum toxin), breast health (clinical breast exam technique, breast self-awareness, mammography screening guidelines (ACR, ACOG, USPSTF), evaluation of breast masses (diagnostic mammogram, breast ultrasound, core needle biopsy, fine needle aspiration, MRI), breast pain (mastalgia) evaluation and management, nipple discharge evaluation (galactorrhea workup, pathologic discharge workup), benign breast conditions (fibrocystic changes (cyclic mastalgia management), fibroadenomas (observation, cryoablation, surgical excision), cysts (simple vs complex management), intraductal papilloma), cervical cancer prevention and screening (HPV vaccination (age recommendations, catch-up vaccination, shared clinical decision-making), Pap smear (LBC, conventional) preparation, collection technique, interpretation (Bethesda system: NILM, ASC-US, LSIL, ASC-H, HSIL, AGC, carcinoma), HPV testing (primary HPV screening, co-testing), colposcopy indications, technique, and findings (acetowhite epithelium, punctation, mosaicism, atypical vessels), cervical intraepithelial neoplasia (CIN) management (CIN 1 observation, CIN 2/3 treatment (LEEP, CKC, ablation)), abnormal uterine bleeding (AUB) evaluation (history, physical exam, labs (CBC, TSH, prolactin, FSH, pregnancy test), imaging (transvaginal ultrasound, saline infusion sonography, MRI), PALM-COEIN classification system (Polyp, Adenomyosis, Leiomyoma, Malignancy/hyperplasia, Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not yet classified), polycystic ovary syndrome (PCOS) diagnosis (Rotterdam criteria (2 of 3: oligo/anovulation, clinical/biochemical hyperandrogenism, polycystic ovaries on ultrasound)), management (lifestyle modification (diet, exercise, weight loss), hormonal contraceptives for cycle regulation and androgen blockade, metformin for metabolic dysfunction, anti-androgens (spironolactone, finasteride) for hirsutism/acne, fertility treatment (letrozole, clomiphene, gonadotropins, IVF)), endometriosis diagnosis (clinical presentation (dysmenorrhea, dyspareunia, dyschezia, dysuria, chronic pelvic pain), surgical diagnosis via laparoscopy with biopsy) and management (NSAIDs, hormonal suppression (combined oral contraceptives, progestins, GnRH agonists (leuprolide) with add-back therapy, GnRH antagonists (elagolix, relugolix), danazol, aromatase inhibitors), surgical excision, hysterectomy), uterine fibroids (leiomyomas) classification (FIGO classification system), symptoms (heavy menstrual bleeding, bulk symptoms, reproductive dysfunction), management (watchful waiting, medical therapy (NSAIDs, tranexamic acid, GnRH agonists, oral contraceptives, progestin-releasing IUD, elagolix/relugolix combination), minimally invasive procedures (uterine artery embolization (UAE), radiofrequency ablation (Acessa, Sonata), MRI-guided focused ultrasound), surgical options (myomectomy (abdominal, laparoscopic, robotic, hysteroscopic), hysterectomy)), ovarian cysts (functional cysts (follicular cysts, corpus luteum cysts) management (observation, oral contraceptives), pathologic cysts (dermoid/mature cystic teratoma, cystadenoma (serous/mucinous), endometrioma, malignancy), complications (ovarian torsion (surgical emergency, oophorectomy/oophoropexy), rupture, hemorrhage), menopause and perimenopause management (stages of reproductive aging (STRAW+10 criteria), menopause transition symptoms (vasomotor symptoms (hot flashes, night sweats), genitourinary syndrome of menopause (GSM), sleep disturbances, mood changes, cognitive complaints), hormone therapy (estrogen therapy (ET) for hysterectomized women, estrogen plus progestogen therapy (EPT) for women with intact uterus, dosing (standard vs low dose), routes (oral, transdermal patch/gel/emulsion/spray, vaginal ring/cream/tablet), risks and benefits (WHI study findings), non-hormonal pharmacologic options for vasomotor symptoms (SSRIs (paroxetine, escitalopram, citalopram), SNRIs (venlafaxine, desvenlafaxine), gabapentin, pregabalin, clonidine), management of GSM (vaginal moisturizers, lubricants, vaginal estrogen (cream, ring, tablet), vaginal DHEA (prasterone), oral ospemifene), bone health (osteoporosis screening (DXA scan, FRAX tool), prevention and treatment (calcium, vitamin D, bisphosphonates (alendronate, risedronate, zoledronic acid, ibandronate), denosumab, raloxifene, teriparatide, abaloparatide)), reproductive health in special populations (adolescent reproductive health (confidentiality, consent, contraception access, STI screening, HPV vaccination, menstrual disorders), LGBTQ+ health (transgender care (gender-affirming hormone therapy (estrogen/testosterone), fertility preservation, sexual health screening, cervical cancer screening in transgender men, breast cancer screening in transgender women), women with disabilities (access to care, reproductive autonomy, contraception, pregnancy care), survivors of intimate partner violence (IPV) and sexual trauma (trauma-informed care, screening (HARK, HUM, PVS), safety planning, resources), ethical and legal issues (informed consent for contraception and procedures, confidentiality (minor consent laws, Title X), mandatory reporting (child abuse, elder abuse, reportable diseases), reproductive rights (contraception access, abortion access following Dobbs decision), cultural competence in reproductive health, shared decision-making, health literacy, motivational interviewing, and evidence-based clinical guidelines from ACOG (American College of Obstetricians and Gynecologists), ASRM (American Society for Reproductive Medicine), CDC (Centers for Disease Control and Prevention) STI Treatment Guidelines, USPSTF (U.S. Preventive Services Task Force), WHO (World Health Organization), and the Endocrine Society, each answer includes detailed clinical rationales to reinforce advanced practice nursing skills in reproductive health care. Perfect for WHNP, FNP, and advanced practice nursing students preparing for the NRNP 6552 Week 6 Midterm Exam at Walden University. With our Pass Guarantee, you can confidently prepare for your Advanced Reproductive Health Care exam. Download your complete NRNP 6552 Week 6 Midterm Exam with 100 questions and verified answers instantly!

Vista previa del contenido

NRNP 6552 WEEK 6 MIDTERM EXAM 2026 | Advanced
Reproductive Health Care | 100 Questions & Verified Answers
| Walden University | Pass Guaranteed - A+ Graded




Section 1: Female Reproductive Anatomy & Physiology (Questions 1–12)


Q1: A 14-year-old patient presents with breast budding and sparse pubic hair. Her
mother is concerned about the timing of puberty. According to Tanner staging, which
stage best describes this presentation?


A. Tanner Stage 1


B. Tanner Stage 2 [CORRECT]


C. Tanner Stage 3


D. Tanner Stage 4


Correct Answer: B


Rationale: For the NRNP6552 Week 6 midterm, remember that Tanner Stage 2
represents thelarche (breast budding) and sparse pubic hair growth—the earliest visible
signs of puberty. Stage 1 is prepubertal with no development, Stage 3 shows further

,breast enlargement and darker coarser hair, and Stage 4 has adult-type hair with smaller
breast contour. Knowing the sequence helps you counsel families about normal
pubertal progression.




Q2: During the follicular phase of the ovarian cycle, which hormone is primarily
responsible for stimulating follicular development and endometrial proliferation?


A. Progesterone


B. Luteinizing hormone


C. Follicle-stimulating hormone [CORRECT]


D. Prolactin


Correct Answer: C


Rationale: Follicle-stimulating hormone (FSH) is the key driver of follicular development
in the ovary during the follicular phase, and the developing follicles produce estrogen
which stimulates endometrial proliferation. Progesterone dominates the luteal phase,
LH triggers ovulation, and prolactin is involved in lactation—not the ovarian cycle. A
common midterm trap is confusing which hormone drives which phase.

,Q3: A 25-year-old patient reports her menstrual cycles range from 24 to 32 days, with
bleeding lasting 4 days and using about 6 regular tampons per day. Which statement
about her cycle is most accurate?


A. Her cycle is abnormally short and requires evaluation


B. Her menstrual flow is excessive and suggests a bleeding disorder


C. Her cycle falls within normal parameters [CORRECT]


D. Her cycle length variability indicates anovulation


Correct Answer: C


Rationale: Normal menstrual cycles range from 21-35 days in length, with flow lasting
2-7 days and blood loss of 20-80 mL. This patient's 24-32 day cycles, 4-day duration,
and moderate flow (6 regular tampons/day is within normal) all fall within normal
parameters. Cycle variability up to 7-9 days is also considered normal in
reproductive-aged women. Don't over-medicalize normal variations that many women
experience.




Q4: Which hormone primarily maintains the secretory phase of the endometrial cycle
and prepares the endometrium for potential implantation?


A. Estrogen

, B. Follicle-stimulating hormone


C. Progesterone [CORRECT]


D. Human chorionic gonadotropin


Correct Answer: C


Rationale: Progesterone, produced by the corpus luteum after ovulation, transforms the
estrogen-primed proliferative endometrium into a secretory endometrium with
glycogen-rich glands and increased vascularization—creating the ideal environment for
embryo implantation. Estrogen drives proliferation, FSH stimulates follicles, and hCG is
produced after implantation to maintain the corpus luteum. Understanding this
hormonal interplay is essential for evaluating luteal phase defects and infertility.




Q5: A 50-year-old patient reports irregular cycles, hot flashes, and vaginal dryness. Her
last menstrual period was 8 months ago. According to STRAW+10 staging, which stage
best describes her status?


A. Late reproductive


B. Early menopausal transition


C. Late menopausal transition [CORRECT]


D. Early postmenopause

Información del documento

Subido en
22 de abril de 2026
Número de páginas
84
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$28.50

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
NURSEEXAMITY
3.4
(108)
Vendido
574
Seguidores
275
Artículos
6739
Última venta
8 horas hace




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes